3Guo H,Lee JD,Xing Y,et al.Changes of homocysteine levels and arterial endothelial function in patients vith high risk of coronary artery disease after 6-month folic acid supplementation[J].Acta Cardiol,2004:59(5):503-506.
4Ueland PM,Refsum H,Stabler SP,et al.Total homocysteine in plasma or serum:methods and clinical applications[J].Clin chem,1993:39(9):1764-1779.
5Marin E,Sessa WC.Role of endothelial-derived nitric oxide in hypertension and renal disease[J].Curr Opin Nephrol Hypertens,2007:16(2):105-1010.
6Biasioli S, Schiavon R. Homocysteine as a cardiovascular risk factor [J].Blood Purif,2000;18(3) :177-82.
7Guo H, Lee JD, Xing Y,et al. Changes of homocysteine levels and arterial endothelial function in patients with high risk of coronary artery disease after 6-month folic acid supplementation[J]. Acta Cardiol,2004 ;59 (5) :503-6.
8Ueland PM, Refsum H , Stabler SP, et al. Total homocysteine in plasma or serum : methods and clinical applications [J]. Clin Chem, 1993 ; 39 (9) : 1764-79.
9Selhub J, Jacques PF , Wilson PW, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population [J]. JAMA, 1993 ; 270(22) :2693-8.
10Chia S, Wilson R, Ludlam CA, et al. Endothelial dysfunction in patients with recent myocardial infarction and hyperhomocysteinaemia: effects of vitamin supplementation[J]. Clin Sci (Lond) ,2005 ; 108 ( 1 ) :65-72.
